You are here: Industry Insights > COVID-19 Vaccine

News List

Serum Institute seeks DCGI nod for phase2/3 trials of Oxford’s COVID-19 vaccine expresspharma
July 27, 2020
According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covidshield' in healthy Indian adults.
UK invests $127m to scale up Covid-19 vaccine manufacturing pharmaceutical-technology.
July 24, 2020
The Government of UK has announced an investment of £100m ($127m) to scale up manufacturing of Covid-19 vaccine and gene therapy in the country.
US to pay Pfizer, BioNTech $1.95 billion for COVID-19 vaccine expresspharma
July 24, 2020
The contract for 100 million doses of the vaccine amounts to a $39 price tag for what is likely to be a two-dose course of treatment.
Promise and prevention: Experts discuss the race for a COVID-19 vaccine expresspharma
July 24, 2020
As the global race for a COVID-19 vaccine heats up, Reuters invited a group of healthcare experts to answer questions as part of our #AskReuters Twitter chat series.
Plant-based COVID-19 vaccine enters Phase I trials europeanpharmaceuticalreview
July 23, 2020
The vaccine containing a recombinant coronavirus virus-like particles (CoVLP) will be tested in three different doses and with two different adjuvants.
Bavarian Nordic licences Covid-19 vaccine from AdaptVac pharmaceutical-technology
July 23, 2020
Bavarian Nordic has signed a final agreement with AdaptVac to licence a capsid virus-like particle (cVLP) based SARS-CoV-2 subunit vaccine.
US inks $1.95bn deal for Pfizer and BioNTech’s Covid-19 vaccine pharmaceutical-technology
July 23, 2020
The US Department of Health and Human Services (HHS) and the Department of Defense have executed an agreement valued at $1.95bn with Pfizer and BioNTech for up to 600 million doses of the companies’ Covid-19 vaccine candidate, BNT162.
Brazil approves human trials for third COVID-19 vaccine in collaboration with Pfizer, BioNTech expresspharma
July 23, 2020
The country is also scrambling to secure supplies of potential vaccines, in case they are proven successful.
Interim data shows strong responses to AZ/Oxford Uni's COVID-19 vaccine pharmatimes
July 22, 2020
A vaccine against SARS-CoV-2 being developed by AstraZeneca and the University of Oxford is showing strong promise in clinical trials.
COVID-19 vaccine safely induces immune response in Chinese trial europeanpharmaceuticalreview
July 22, 2020
Investigators report CanSino Biologics’ Ad5-nCoV vaccine induced antibody production with mild to moderate side effects in patients.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page